| Literature DB >> 29581751 |
Jing Quan1,2,3, Xiang Pan1,2,3, Tao He1,3, Canbin Lin1,3, Yulin Lai1,3, Peijie Chen1,3, Zeng Zhang2,3, Shangqi Yang1, Tao Wang4, Yongqing Lai1,3.
Abstract
Increasing evidence has demonstrated that microRNA (miRNA) serve an important role in the tumorigenesis of various types of cancer, such as renal cell carcinoma (RCC). The expression of miR-211-5p has been detected in RCC tissue by microarray profiling. However, studies regarding miR-211-5p and RCC remain rare. In the present study, the expression of miR-211-5p in RCC tissues and cell lines was revealed to be downregulated by reverse transcription-quantitative polymerase chain reaction analyses. The present results also revealed that the upregulation or downregulation of miR-211-5p inhibited or promoted, respectively, RCC cell proliferation, migration and invasion. In addition, the upregulation or downregulation of miR-211-5p induced or inhibited, respectively, RCC cell apoptosis. However, the present study only identified that downregulation of miR-211-5p promoted 786O and ACHN cell viability. The above results suggest that miR-211-5p may be a tumor suppressor in the tumorigenesis of RCC and may be a potential therapeutic target for RCC in the future. Further research should focus on the underlying mechanism of miR-211-5p in RCC and on investigating the possible use of miR-211-5p as a biomarker for RCC.Entities:
Keywords: miR-211-5p; microRNA; renal cell carcinoma; tumor suppressor
Year: 2018 PMID: 29581751 PMCID: PMC5863605 DOI: 10.3892/etm.2018.5908
Source DB: PubMed Journal: Exp Ther Med ISSN: 1792-0981 Impact factor: 2.447